Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-20

FDA Approved: FULVESTRANT — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved Fulvestrant through an Original Application (NDA210326) for Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fulvestrant (fulvestrant)

Snippet

ORIG AP for FULVESTRANT (FULVESTRANT)